EC Number   |
|---|
   2.4.1.150 | - |
| 2.4.1.150 | 2 isoforms IGnT A and IGnT B are produced by alternative splicing of the IGnT gene, the C-terminal 1/4 of IGnT B is identical to that of IGnT A |
| 2.4.1.150 | C2GnT and IGnT cDNAs are cloned and sequenced, genes are both localized on chromosome 9, band q2l, genomic structures |
| 2.4.1.150 | cDNA encoding IGnT is cloned from PA-1 cells, 400-amino acids protein |
| 2.4.1.150 | cDNA inserted into a mammalian expression vector, pSVK3 and overexpressed in COS-1 cells |
| 2.4.1.150 | cotransfection and expression of Epstein-Barr virus (EBV) miRNA miR-BART1-5p and GCNT3 in HEK-293T and SGC7901 cells |
| 2.4.1.150 | expression of each isoform is controlled by a different promoter, characterization of the promoters: GT boxes play crucial roles in transcriptional regulation of the genes |
| 2.4.1.150 | gene GCNT2, genotyping |
| 2.4.1.150 | gene GCNT3, genotyping |
| 2.4.1.150 | gene GCNT3, recombinant overexpression in SW620 and SW5FU cell lines, genomic analysis of GCNT3 overexpression, quantitative RT-PCR enzyme expression analysis, genomic and proteomic landscapes of GCNT3 are linked to cell cycle and response to drug pathways. GCNT3 overexpression does not significantly change cell growth in Caov3 cells, VEGFA expression is downregulated in GCNT3 Caov3 cells |
